U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07508618) titled 'Study on the Prevention of Atrial Fibrillation Recurrence After Ablation by Qidong Yixin Granule' on March 27.
Brief Summary: The goal of this clinical trial is to investigate the efficacy and safety of Qidong Yixin Granules in preventing recurrence in patients after radiofrequency catheter ablation for atrial fibrillation. The main question it aims to answer is:
Can Qidong Yixin Granules reduce the recurrence rate of atrial fibrillation within 1 year in patients undergoing radiofrequency catheter ablation for atrial fibrillation?
Participants will be randomly assigned, with a 50% chance of being allocated to either the study grou...